In situ gelling, bioadhesive nasal inserts for extended drug delivery: In vitro characterization of a new nasal dosage form

被引:139
作者
Bertram, U [1 ]
Bodmeier, R [1 ]
机构
[1] Free Univ Berlin, Coll Pharm, D-12169 Berlin, Germany
关键词
bioadhesion; extended drug release; freeze-drying; hydrogels; hydrophilic polymers; inserts; nasal drug delivery;
D O I
10.1016/j.ejps.2005.08.005
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The purpose of this study was the preparation and characterization of sponge-like, in situ gelling inserts based on bioadhesive polymers. Hydrophilic polymers (carrageenan, Carbopol, chitosan, hydroxypropyl methylcellulose (HPMC) K15M and ES, sodium alginate, sodium carboxy methylcellulose (NaCMC), polyvinyl pyrrolidone (PVP) 90, xanthan gum) were dissolved with/without the model drug oxymetazoline HCl in demineralized water and lyophilized into small inserts. The drug release, water uptake, mechanical properties, X-ray diffraction and bioadhesion potential of the nasal inserts were investigated. A sponge-like structure of nasal inserts was formed with amorphous, but not with crystalline polymers during the freeze-drying process. The insert hardness increased with the glass transition temperature of the polymer (PVP25 < PVP30 < PVP90). The bioadhesion potential was governed by the polymer ability to interact with mucin/agar (highest for carrageenan, Carbopol, xanthan gum and NaCMC). Inserts prepared from low molecular weight polymers resulted in polymer dissolution and fast drug release (HPMC ES, Na-alginate, PVP90). The drug release from inserts prepared from high molecular weight polymers (carrageenan, Carbopol, chitosan, HPMC K15M, NaCMC, xanthan gum) was a complex interplay of osmotic forces, water uptake and electrostatic interactions between drug and polymer. The drug release decreased with higher polymer content and increased drug loading of the insert. Bioadhesive nasal inserts have a high potential as new nasal dosage form for extended drug delivery. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:62 / 71
页数:10
相关论文
共 36 条
[1]  
AZRIA M, 1986, Patent No. 3617728
[2]   STARCH MICROSPHERES INDUCE PULSATILE DELIVERY OF DRUGS AND PEPTIDES ACROSS THE EPITHELIAL BARRIER BY REVERSIBLE SEPARATION OF THE TIGHT JUNCTIONS [J].
BJORK, E ;
ISAKSSON, U ;
EDMAN, P ;
ARTURSSON, P .
JOURNAL OF DRUG TARGETING, 1995, 2 (06) :501-507
[3]   CHARACTERIZATION OF DEGRADABLE STARCH MICROSPHERES AS A NASAL DELIVERY SYSTEM FOR DRUGS [J].
BJORK, E ;
EDMAN, P .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 62 (2-3) :187-192
[4]  
BODMEIER R, 1999, Patent No. 19756314
[5]  
BUHLER V, 1999, KOLLIDON POLYVINYLPY
[6]   Evaluation of starch-maltodextrin-Carbopol® 974 P mixtures for the nasal delivery of insulin in rabbits [J].
Callens, C ;
Remon, JP .
JOURNAL OF CONTROLLED RELEASE, 2000, 66 (2-3) :215-220
[7]   NASAL ABSORPTION OF DESMOPRESSIN IN RATS AND SHEEP - EFFECT OF A BIOADHESIVE MICROSPHERE DELIVERY SYSTEM [J].
CRITCHLEY, H ;
DAVIS, SS ;
FARRAJ, NF ;
ILLUM, L .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1994, 46 (08) :651-656
[8]   Stabilization and controlled release of bovine serum albumin encapsulated in poly(D, L-lactide) and poly(ethylene glycol) microsphere blends [J].
Jiang, WL ;
Schwendeman, SP .
PHARMACEUTICAL RESEARCH, 2001, 18 (06) :878-885
[9]  
JUNGINGER HE, 1991, PHARM IND, V53, P1056
[10]   Nasal delivery systems and their effect on deposition and absorption [J].
Kublik, H ;
Vidgren, MT .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 29 (1-2) :157-177